Clinical trial

Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease

NCT04157933

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-10-16

PhasePHASE1

Study timeline

Study start (actual)2019-10-16Date precision: day

Registry last updated2020-11-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

009-B1 (active --> placebo) crossoverDRUG

009-B2 (placebo --> active) crossoverDRUG

Sponsors & collaborators

Alexza Pharmaceuticals, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04157933 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.